Operating Lease, Right-of-Use Asset of RHYTHM PHARMACEUTICALS, INC. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
RHYTHM PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • RHYTHM PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $3,049,000, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $3,049,000 -$428,000 -12% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $3,158,000 -$430,000 -12% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $3,262,000 -$434,000 -12% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $3,367,000 +$2,697,000 +403% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $3,477,000 +$2,696,000 +345% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $3,588,000 +$2,700,000 +304% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $3,696,000 +$2,706,000 +273% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $670,000 -$418,000 -38% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $781,000 -$401,000 -34% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $888,000 -$385,000 -30% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $990,000 -$369,000 -27% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $1,088,000 -$354,000 -25% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $1,182,000 -$340,000 -22% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $1,273,000 -$325,000 -20% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $1,359,000 -$312,000 -19% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $1,442,000 -$299,000 -17% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $1,522,000 -$285,000 -16% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $1,598,000 -$273,000 -15% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $1,671,000 -$261,000 -14% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $1,741,000 -$248,000 -12% 31 Mar 2021 10-Q 03 May 2021 2021 Q1
Q4 2020 $1,807,000 -$238,000 -12% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $1,871,000 -$226,000 -11% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $1,932,000 -$1,153,000 -37% 30 Jun 2020 10-Q 03 Aug 2020 2020 Q2
Q1 2020 $1,989,000 -$1,185,000 -37% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 $2,045,000 -$1,220,000 -37% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $2,097,000 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $3,085,000 30 Jun 2019 10-Q 29 Jul 2019 2019 Q2
Q1 2019 $3,174,000 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 $3,265,000 31 Dec 2018 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.